Power Doppler sonography of invasive breast carcinoma: Does tumor vascularization contribute to prediction of axillary status?

Radiology

Volumn 234, Issue 2, 2005, Pages 374-380

  Santamaría, Gorane ^a   Velasco, Martín ^a   Farré, Xavier ^a   Vanrell, Juan Antonio ^a   Cardesa, Antonio ^a   Fernández, Pedro Luis ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CONTROLLED STUDY; DISSECTION; DOPPLER FLOWMETRY; ECHOGRAPHY; FEMALE; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFORMED CONSENT; INVASIVE CARCINOMA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTECTOMY; MICROVASCULARIZATION; PARTIAL MASTECTOMY; PRIORITY JOURNAL; PROFESSIONAL STANDARD; TUMOR VASCULARIZATION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; PASTEURELLACEAE; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; ROC CURVE; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, DOPPLER;

EID: 12344308050     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2342031252     Document Type: Article

References (31)

1. Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol 1992; 3:65-71.
2. Srivastava A, Laidler P, Davies R, Horgan K, Hughes LE. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. Am J Pathol 1988; 133:419-423.
3. Weidner N, Semple JP, Welch WR. Tumor angiogenesis and metastasis correlation in invasive breast carcinoma. N Engl J Med 1991; 324:1-8.
4. Weidner N, Folkman J, Pozza F. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992; 84:1875-1887.
5. Martin L, Green B, Renshaw C, et al. Examining the technique of angiogenesis assessment in invasive breast cancer. Br J Cancer 1997; 76:1046-1054.
6. Peters-Engl C, Medl M, Mirau M, et al. Color-coded and spectral Doppler flow in breast carcinomas: relationship with the tumor microvasculature. Breast Cancer Res Treat 1998; 47:83-89.
7. Delorme S, Knopp MV. Non-invasive vascular imaging: assessing tumour vascularity. Eur Radiol 1998; 8:517-527.
8. Fanelli M, Locopo N, Gattuso D, Gasparini G. Assessment of tumor vascularization: immunohistochemical and non-invasive methods. Int J Biol Markers 1999; 14:218-231.
9. Bude RO, Rubin JM. Power Doppler sonography. Radiology 1996; 200:21-23.
10. Fitzgibbons PL, Page DL, Weaver D et al. Prognostic factors in breast cancer: College of American Pathologists consensus statement 1999. Arch Pathol Lab Med 2000; 124:966-978.
11. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer: a multicenter validation study. N Engl J Med 1998; 339:941-946.
12. Keshtgar MR, Ell PJ. Clinical role of sentinel-lymph-node biopsy in breast cancer. Lancet Oncol 2002; 3:105-110.
13. Ross MI. Sentinel node dissection in early-stage breast cancer: ongoing prospective randomized trials in the USA. Ann Surg Oncol 2001; 8(suppl 9):77S-81S.
14. Allan SM, Kedar RP, Cosgrove DO, Sacks NP. Colour Doppler ultrasound for axillary lymph node staging in breast cancer. Breast 1994; 3:94-96.
15. Yang WT, Chang J, Metreweli C. Patients with breast cancer: differences in color Doppler flow and gray-scale US features of benign and malignant axillary lymph nodes. Radiology 2000; 215:568-573.
16. Sterns EE, SenGupta S, Saunders F, Zee B. Vascularity demonstrated by Doppler ultrasound and immunohistochemistry in invasive ductal carcinoma of the breast. Breast Cancer Res Treat 1996; 40:197-203.
17. Mehta TS, Raza S. Power Doppler sonography of breast cancer: does vascularity correlate with node status or lymphatic vascular invasion? AJR Am J Roentgenol 1999; 173:303-307.
18. Delorme S, Anton HW, Knopp MV, et al. Breast cancer: assessment of vascularity by colour Doppler. Eur Radiol 1993; 3:253-257.
19. Mehta TS, Raza S, Baum JK. Use of Doppler ultrasound in the evaluation of breast carcinoma. Semin Ultrasound CT MR 2000; 21:297-307.
20. Raza S, Baum JK. Solid breast lesions: evaluation with power Doppler US. Radiology 1997; 203:164-168.
21. Delorme S, Peschke P, Zuna I, Van Kaick G. Sensitivity of color Doppler sonography: an experimental approach. Ultrasound Med Biol 1999; 25:541-547.
22. Less JR, Skalak TC, Sevick EM, Jain RK. Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions. Cancer Res 1991; 51: 265-273.
23. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33:159-174.
24. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1:307-310.
25. Cosgrove DO, Kedar RP, Bamber JC, et al. Breast diseases: color Doppler US in differential diagnosis. Radiology 1993; 189: 99-104.
26. Holcombe C, Pugh N, Lyons K, Douglas-Jones A, Mansel RE, Morgan K. Blood flow in breast cancer and fibroadenoma estimated by color Doppler US. Br J Surg 1995; 82:787-788.
27. Birdwell RL, Ikeda DM, Jeffrey SS, Jeffrey RB. Preliminary experience with power Doppler imaging of solid breast masses. AJR Am J Roentgenol 1997; 169:703-707.
28. Rosen PP, Groshen S. Factors influencing survival and prognosis in early breast carcinoma (T1N0M0-T1N1M0): assessment of 644 patients with median follow up of 19 years. Surg Clin North Am 1990; 70: 937-962.
29. Byers SW, Sommers CL, Hoxter B, Mercurio AM, Tozeren A. Role of E-cadherin in the response of tumor cell aggregates to lymphatic, venous and arterial flow: measurement of cell-cell adhesion strength. J Cell Sci 1995; 108:2053-2064.
30. Moon WK, Im JG, Noh DY, Han MC. Nonpalpable breast lesions: evaluation with power Doppler US and a microbubble contrast agent-initial experience. Radiology 2000; 217:240-246.
31. Schroeder RJ, Maeurer J, Vogl TJ, et al. D-galactose-based signal enhanced color Doppler sonography of breast tumors and tumorlike lesions. Invest Radiol 1999; 34: 109-115.